2012, COVID-19 and Prescription Drug Pricing - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

COVID-19

Prescription Drug Pricing

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

JULY 18, 2024

growth for group health insurance plans is the highest rate of medical cost trend growth since 2012. Note, too, the driving cost-force of behavioral health, which has grown in adoption as the COVID-19 pandemic revealed the unmet and fast-growing need for mental health care — across the generations. and 7.0%, respectively.

Doctors

Doctors Prescription Drug Pricing Hospitals Health Insurance

Democrats Didn’t Achieve All Their Goals, but Inflation Reduction Act Makes Historic Medicare Changes

Kaiser Health News

AUGUST 12, 2022

Second, it would extend the enhanced premium subsidies for people who buy insurance on the Affordable Care Act marketplaces that Congress put in place last year to help confront the covid-19 pandemic. Never before have we been able to negotiate prescription drug prices. “It’s historic.

Medicare

Medicare Medicare Prescription Drug Pricing Governance

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Democrats Didn’t Achieve All Their Goals, but Inflation Reduction Act Makes Historic Medicare Changes

Stay Connected